tiprankstipranks
Trending News
More News >
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
US Market
Advertisement

Royalty Pharma (RPRX) Technical Analysis

Compare
1,291 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Royalty Pharma PLC’s (RPRX) Moving Averages Convergence Divergence (MACD) indicator is 0.79, suggesting Royalty Pharma PLC is a Sell.
Royalty Pharma PLC’s (RPRX) 20-Day exponential moving average is 37.61, while Royalty Pharma PLC’s (RPRX) share price is $38.56, making it a Buy.
Royalty Pharma PLC’s (RPRX) 50-Day exponential moving average is 36.78, while Royalty Pharma PLC’s (RPRX) share price is $38.56, making it a Buy.

Royalty Pharma (RPRX) Pivot Points

Nov 09, 2025, 04:24 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
38.90
39.46
40.12
40.68
41.34
41.90
42.56
Fibonacci
39.46
39.93
40.21
40.68
41.15
41.43
41.90
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Royalty Pharma (RPRX) Moving Averages

Nov 09, 2025, 04:24 PM
Period
Simple
Exponential
MA5
38.98Sell
38.98Sell
MA10
37.97Buy
38.34Buy
MA20
37.29Buy
37.61Buy
MA50
36.50Buy
36.78Buy
MA100
36.28Buy
35.86Buy
MA200
34.28Buy
33.62Buy
Royalty Pharma PLC’s (RPRX) 10-Day exponential moving average is 38.34, while Royalty Pharma PLC’s (RPRX) share price is $38.56, making it a Buy.
Royalty Pharma PLC’s (RPRX) 100-Day exponential moving average is 35.86, while Royalty Pharma PLC’s (RPRX) share price is $38.56, making it a Buy.
Royalty Pharma PLC’s (RPRX) stock price is $38.56 and Royalty Pharma PLC’s (RPRX) 50-day simple moving average is 36.50, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) stock price is $38.56 and Royalty Pharma PLC’s (RPRX) 100-day simple moving average is 36.28, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) stock price is $38.56 and Royalty Pharma PLC’s (RPRX) 200-day simple moving average is 34.28, creating a Buy signal.

Royalty Pharma (RPRX) Technical Indicators

Nov 09, 2025, 04:24 PM
Name
Value
Implied Action
RSI (14)
57.31
Neutral
STOCH (9,6)
76.54
Neutral
STOCHRSI (14)
76.54
Neutral
MACD (12,26)
0.79
Sell
ADX (14)
15.56
Buy
Williams %R
-50.33
Buy
CCI (14)
152.50
Sell
ATR (14)
1.19
-
Ultimate Oscillator
63.33
Neutral
ROC
5.27
Buy
Royalty Pharma PLC’s (RPRX) Relative Strength Index (RSI) is 57.31, creating a Neutral signal.
Royalty Pharma PLC’s (RPRX) Trend Strength Indicator (ADX) is 15.56, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) Commodity Channel Index (CCI) is 152.50, creating a Sell signal.
Royalty Pharma PLC’s (RPRX) Price Rate of Change (ROC) is 5.27, creating a Buy signal.

FAQ

Is RPRX a Buy, Hold, or Sell?
Based on RPRX’s technical indicators, RPRX is a Buy.
    What is RPRX’s RSI (14)?
    RPRX’s RSI (14) is 57.31, which suggests RPRX is a Neutral.
      What is RPRX’s MACD?
      RPRX’s MACD is 0.79, which suggests RPRX is a Sell.
        What is RPRX’s 5-day moving average?
        RPRX’s 5-day moving average is 38.98, which suggests RPRX is a Sell.
          What is RPRX’s 20-day moving average?
          RPRX 20-day moving average is 37.29, which suggests RPRX is a Buy.
            What is RPRX’s 50-day moving average?
            RPRX’s 50-day moving average is 36.50, which suggests RPRX is a Buy.
              What is RPRX’s 200-day moving average?
              RPRX’s 200-day moving average is 34.28, which suggests RPRX is a Buy.
                What is RPRX’s Williams % R (14)?
                RPRX’s Williams % R (14) is -50.33, which suggests RPRX is a Buy.
                  What is RPRX’s CCI (14)?
                  RPRX’s CCI (14) is 152.50, which suggests RPRX is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis